What question did this study set out to answer?

The aim is to evaluate how juvenile nonhuman primates can be used as models for pediatric drug formulations and their effectiveness in HIV prevention and treatment.

February 24, 2026

Juvenile Nonhuman Primate Model: The Past, Present, and Future of a Preclinical Model System for Evaluating Development of New Pediatric Drug Formulations

Key Points

The aim is to evaluate how juvenile nonhuman primates can be used as models for pediatric drug formulations and their effectiveness in HIV prevention and treatment.
Conducted a hybrid workshop on the use of nonhuman primates for HIV research.
Engaged participants from academia, industry, and government.
Focused on developing pediatric formulations and their evaluation.
Highlighted the relevance of juvenile nonhuman primate models in biomedical research.
Emphasized collaborative efforts in advancing pediatric drug development.
Showed strong interest and participation from various sectors to innovate HIV prevention strategies.

Abstract

ABSTRACT A hybrid workshop entitled “NHP Models for HIV Prevention and Treatment: Towards Developing Pediatric Formulations” was organized by the Prevention Sciences Program (PSP) of the Division of AIDS (DAIDS) within the National Institute of Allergy and Infectious Diseases (NIAID), with special assistance from Advanced Biosciences Laboratories Inc. (Rockville, Maryland) and the Tulane National Biomedical Research Center (Covington, Louisiana). The event was held on October 22, 2024, in New Orleans and attracted participants from academia, industry, and government agencies, and included attendees from the 41st Annual Symposium on Nonhuman Primate Models for AIDS.

Juvenile Nonhuman Primate Model: The Past, Present, and Future of a Preclinical Model System for Evaluating Development of New Pediatric Drug Formulations

Key Points

Abstract

Cite This Study